ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.340,57
0,65%
S&P 500
5.909,03
-1,11%
Dow Jones
42.528,36
-0,42%
Euro vs US Dollar
1,03411
-0,41%
Bitcoin
96.696,64
-5,47%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC

  6. Genmab A S (PK) (GNMSF) Börsenkurse

Genmab A S (PK)

Genmab A S (PK) (GNMSF)

USOTC
222,2111
4,90
(2,25%)
Geschlossen 07 Januar 10:00PM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
222,2111
Gebot
199,81
Fragen
224,00
Volumen
278
216,182 Tagesbereich 225,00
192,20 52-Wochen-Bereich 334,328
Marktkapitalisierung
14,597B
Handelsende
217,314
Handelsbeginn
225,00
Letzte Trade
6
@
222.2111
Letzter Handelszeitpunkt
Finanzvolumen
US$ 61.151
VWAP
219,9683
Durchschnittliches Volumen (3 Mio.)
8.241
Ausgegebene Aktien
65.691.573
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
3,18
Gewinn pro Aktie (EPS)
66,25
Erlöse
16,47B
Nettogewinn
4,35B

Über Genmab A S (PK)

Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer. Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.

Sektor
Biological Pds,ex Diagnstics
Branche
Biogenetic (human)
Website
www.genmab.com
Hauptsitz
Copenhagen, Dnk
Gegründet
2000
Genmab A S (PK) is listed in the Biological Pds,ex Diagnstics sector of the OTCMarkets with ticker GNMSF. The last closing price for Genmab A S (PK) was US$217,31. Over the last year, Genmab A S (PK) shares have traded in a share price range of US$ 192,20 to US$ 334,328.

Genmab A S (PK) currently has 65.691.573 shares in issue. The market capitalisation of Genmab A S (PK) is US$14,28 billion. Genmab A S (PK) has a price to earnings ratio (PE ratio) of 3.18.

GNMSF Neueste Nachrichten

Weitere Nachrichten

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

06 November 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

15 Oktober 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

04 Oktober 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

01 Oktober 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

26 September 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

08 August 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

08 August 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

20 Juni 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

18 Juni 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

17 Juni 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
113.95116.69888600787208.26225206.7221622214.31752288CS
44.21111.93169724771218225192.24759207.32866638CS
12-8.4389-3.65874701929230.65237.51192.28241217.22533493CS
26-36.3189-14.0482342475258.53292.8192.25347229.19770075CS
52-100.7889-31.203993808323334.328192.23130236.53720293CS
156-141.1589-38.8471530396363.37470.5192.21631277.27395767CS
2605.51112.54319335487216.7500.92159.451593293.8766985CS

GNMSF - Frequently Asked Questions (FAQ)

What is the current Genmab A S (PK) share price?
The current share price of Genmab A S (PK) is US$ 222,2111
How many Genmab A S (PK) shares are in issue?
Genmab A S (PK) has 65.691.573 shares in issue
What is the market cap of Genmab A S (PK)?
The market capitalisation of Genmab A S (PK) is USD 14,28B
What is the 1 year trading range for Genmab A S (PK) share price?
Genmab A S (PK) has traded in the range of US$ 192,20 to US$ 334,328 during the past year
What is the PE ratio of Genmab A S (PK)?
The price to earnings ratio of Genmab A S (PK) is 3,18
What is the cash to sales ratio of Genmab A S (PK)?
The cash to sales ratio of Genmab A S (PK) is 0,84
What is the reporting currency for Genmab A S (PK)?
Genmab A S (PK) reports financial results in DKK
What is the latest annual turnover for Genmab A S (PK)?
The latest annual turnover of Genmab A S (PK) is DKK 16,47B
What is the latest annual profit for Genmab A S (PK)?
The latest annual profit of Genmab A S (PK) is DKK 4,35B
What is the registered address of Genmab A S (PK)?
The registered address for Genmab A S (PK) is KALVEBOD BRYGGE 43, COPENHAGEN, 1260
What is the Genmab A S (PK) website address?
The website address for Genmab A S (PK) is www.genmab.com
Which industry sector does Genmab A S (PK) operate in?
Genmab A S (PK) operates in the BIOGENETIC (HUMAN) sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0,008
(799.900,00%)
477
VENGVision Energy Corporation (CE)
US$ 0,0005
(49.900,00%)
10,5k
PLFXPulse Evolution Corporation (CE)
US$ 0,0003
(29.900,00%)
530
EATREastern Asteria Inc (CE)
US$ 0,0003
(29.900,00%)
9,35M
RBSHRebus Holdings Inc (CE)
US$ 0,0001
(9.900,00%)
402
FPWMCharlestowne Premium Beverages Inc (CE)
US$ 0,000001
(-100,00%)
1.000
ZHCLFZenith Capital Corporation (CE)
US$ 0,0001
(-99,86%)
7,95k
CRGPCalissio Resources Group Inc (CE)
US$ 0,000001
(-99,75%)
28k
NEOMNeoMedia Technologies Inc (CE)
US$ 0,000001
(-99,50%)
114,32k
DOCKFBeyond Med Technologies Inc (PK)
US$ 0,0001
(-99,50%)
745
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0,004
(-13,04%)
331,01M
HMBLHUMBL Inc (PK)
US$ 0,00085
(-5,56%)
288,72M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0,0001
(-50,00%)
250,92M
TKMOTekumo Inc (PK)
US$ 0,0003
(0,00%)
201,65M
ASIIAccredited Solutions Inc (PK)
US$ 0,0007
(40,00%)
192,43M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

USOTC
GNMSF
Genmab A S (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten